Stockreport

Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia (fitusiran), the first antithrombin-lowering therapy in [Read more]